Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma |
Columbia University Medical Center / Darrell Yamashiro, MD, PhD |
Innovation Grants |
2013 |
New York |
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma
|
Beckman Research Institute of City of Hope / Margarita Gutova, MD |
Reach Grants |
2013 |
California |
DNA Damage Responses Coordinate Survival and Cell Death Switching In Lymphocytes |
Washington University / Jeffrey Bednarski, MD, PhD |
'A' Award Grants |
2013 |
Missouri |
Identification of Risk Factors for Pediatric Brain Tumors in a High Risk Population |
Washington University / Kimberly Johnson, PhD, MPH |
Epidemiology Grants |
2013 |
Missouri |
The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor |
Washington University / Laura Schuettpelz, MD, PhD |
Young Investigator Grants |
2013 |
Missouri |
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD, PhD |
Reach Grants |
2013 |
Michigan |
Pre-Clinical Testing of T cells Coded with CARs for DIPG |
University of Texas / Laurence Cooper, MD, PhD |
Innovation Grants |
2013 |
Texas |
Function of the PR Domain of the MDSI-EVI1 in MLL Fusion Protein Leukemogenesis |
University of Rochester / Archibald Perkins, MD, PhD |
Springboard Grants |
2013 |
New York |
Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant
|
University of Pittsburgh / Jean Tersak, MD |
Phase I/II Infrastructure Grants |
2013 |
Pennsylvania |
Mechanisms Regulating Medulloblastoma Progression |
University of Pennsylvania / Nadia Dahmane, PhD |
Innovation Grants |
2013 |
Pennsylvania |